Bongers V, Braakhuis B J, Tobi H, Lubsen H, Snow G B
Department of Otorhinolaryngology and Head and Neck Surgery, Free University Hospital, Amsterdam, The Netherlands.
Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):595-8.
Despite improvement in therapeutic modalities in head and neck squamous cell carcinoma (HNSCC) the overall survival rate has only marginally improved during the last decades. The occurrence of second primary tumors (SPTs) in the respiratory and upper digestive tract (RUDT) is the main cause of treatment failure in early stage HNSCC. Identification of risk factors for the development of SPT by epidemiological analysis may lead to better risk assessment in individual cases. Ninety-seven HNSCC patients who ultimately developed SPTs and 100 HNSCC patients who remained free of other carcinomas after treatment of the first for a minimal period of 6 years were interviewed about the incidence of RUDT carcinomas within parents and siblings. All questioned patients were smokers. Among the SPT-positive patients, 50 (8.9%) of the 562 family members were reported to have had cancer of the respiratory or upper digestive tract versus 16 (2.5%) of the 629 family members of the SPT-negative patients. This difference was statistically significant (P < 0.0001) with the stratified version of Fisher's exact test. All these 66 probands with RUDT cancer were smokers, and the percentages of smokers were similar in both proband groups. Neither age and sex of the patient, nor tumor stage influenced the occurrence of SPTs in this study. The percentages of probands with tumors outside the RUDTs were almost similar, 8.0 and 7.0% in the SPT-positive and -negative groups, respectively. Having one or more relatives with RUDT cancer was established as a risk factor (odds ratio, 3.8; 95% confidence interval, 2.0-7.6) for patients with initial HNSCC to develop an SPT. These findings suggest that, in addition to external carcinogens, an intrinsic susceptibility may influence the risk for the development of SPTs in HNSCC patients.
尽管头颈部鳞状细胞癌(HNSCC)的治疗方式有所改进,但在过去几十年中总体生存率仅略有提高。呼吸道和上消化道(RUDT)中第二原发性肿瘤(SPT)的发生是早期HNSCC治疗失败的主要原因。通过流行病学分析确定SPT发生的危险因素可能会在个体病例中实现更好的风险评估。对97例最终发生SPT的HNSCC患者和100例在首次治疗后至少6年未患其他癌症的HNSCC患者进行了访谈,询问其父母和兄弟姐妹中RUDT癌的发病率。所有接受询问的患者均为吸烟者。在SPT阳性患者中,562名家庭成员中有50名(8.9%)被报告患有呼吸道或上消化道癌症,而SPT阴性患者的629名家庭成员中有16名(2.5%)患有此类癌症。采用Fisher精确检验的分层版本,这一差异具有统计学意义(P < 0.0001)。所有这66例患有RUDT癌症的先证者均为吸烟者,两个先证者组中的吸烟者百分比相似。在本研究中,患者的年龄和性别以及肿瘤分期均未影响SPT的发生。RUDT以外部位有肿瘤的先证者百分比几乎相似,SPT阳性组和阴性组分别为8.0%和7.0%。有一名或多名患有RUDT癌症的亲属被确定为初始HNSCC患者发生SPT的危险因素(优势比,3.8;95%置信区间,2.0 - 7.6)。这些发现表明,除了外部致癌物外,内在易感性可能会影响HNSCC患者发生SPT的风险。